Vertex Pharmaceuticals Incorporated (VRTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$450.78
Day's range
$461.26

Vertex Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CAPITAL WORLD INVESTORS 05/13/2026 25.37 M $11.33 B   -0.56% 9.92%
BLACKROCK, INC. 05/13/2026 23.97 M $10.70 B   0.92% 9.37%
CAPITAL RESEARCH GLOBAL INVESTORS 05/13/2026 21.13 M $9.43 B   22.00% 8.26%
05/15/2026 16.51 M $7.37 B   100.00% 6.46%
STATE STREET CORP 05/15/2026 11.73 M $5.24 B   0.35% 4.59%
JPMORGAN CHASE & CO 05/13/2026 7.03 M $3.12 B   16.45% 2.75%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 6.14 M $2.73 B   2.64% 2.40%
05/08/2026 5.15 M $2.30 B   100.00% 2.01%
CAPITAL INTERNATIONAL INVESTORS 05/13/2026 5.13 M $2.29 B   8.29% 2.00%
LOOMIS SAYLES & CO L P 05/14/2026 4.00 M $1.79 B   -0.74% 1.57%
ALLIANCEBERNSTEIN L.P. 05/15/2026 3.91 M $1.77 B   -13.03% 1.53%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.21 M $1.43 B   -15.94% 1.26%
MORGAN STANLEY 05/15/2026 3.19 M $1.42 B   2.20% 1.25%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 3.06 M $1.37 B   1.89% 1.20%
BANK OF AMERICA CORP /DE/ 05/18/2026 2.88 M $1.29 B   -2.00% 1.13%
JENNISON ASSOCIATES LLC 05/06/2026 2.74 M $1.22 B   -15.68% 1.07%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 2.70 M $1.21 B   -5.57% 1.06%
AMERIPRISE FINANCIAL INC 05/15/2026 2.63 M $1.18 B   16.33% 1.03%
NORTHERN TRUST CORP 05/14/2026 2.56 M $1.15 B   -0.59% 1.00%
INVESCO LTD. 05/12/2026 2.56 M $1.14 B   18.97% 1.00%
GOLDMAN SACHS GROUP INC 05/15/2026 2.42 M $1.08 B   37.84% 0.95%
JANUS HENDERSON GROUP PLC 05/18/2026 2.13 M $951.79 M   -4.07% 0.83%
FMR LLC 05/15/2026 2.02 M $902.13 M   -8.69% 0.79%
LEGAL & GENERAL GROUP PLC 05/08/2026 1.96 M $873.33 M   -0.73% 0.76%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.92 M $857.75 M   3.32% 0.75%
VICTORY CAPITAL MANAGEMENT INC 05/15/2026 1.89 M $843.33 M   -43.74% 0.74%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.76 M $785.97 M   -22.77% 0.69%
BANK OF NEW YORK MELLON CORP 05/05/2026 1.59 M $708.40 M   3.85% 0.62%
DEUTSCHE BANK AG\ 05/06/2026 1.54 M $686.66 M   -13.07% 0.60%
AMUNDI 05/18/2026 1.47 M $657.53 M   12.91% 0.58%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.47 M $654.50 M   100.00% 0.57%
WCM INVESTMENT MANAGEMENT, LLC 05/07/2026 1.12 M $496.93 M   -0.69% 0.44%
ROYAL BANK OF CANADA 05/15/2026 1.11 M $496.50 M   -6.92% 0.43%
NUVEEN, LLC 04/30/2026 1.08 M $484.27 M   4.04% 0.42%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 989.34 K $441.76 M   4.62% 0.39%
EDGEWOOD MANAGEMENT LLC 05/14/2026 905.13 K $404.18 M   -14.62% 0.35%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 05/14/2026 848.05 K $378.71 M   26.61% 0.33%
AMERICAN CENTURY COMPANIES INC 05/15/2026 813.29 K $363.16 M   -4.17% 0.32%
WELLS FARGO & COMPANY/MN 05/11/2026 745.00 K $332.67 M   0.43% 0.29%
SWISS NATIONAL BANK 05/07/2026 744.60 K $332.49 M   5.98% 0.29%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 702.40 K $313.65 M   19.23% 0.27%
CITIGROUP INC 05/11/2026 682.81 K $304.90 M   26.46% 0.27%
BELLEVUE GROUP AG 05/15/2026 681.91 K $304.50 M   0.12% 0.27%
BARCLAYS PLC 05/15/2026 663.26 K $296.17 M   -21.76% 0.26%
HSBC HOLDINGS PLC 04/30/2026 655.44 K $292.66 M   3.99% 0.26%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 05/14/2026 638.95 K $285.32 M   7.58% 0.25%
UBS GROUP AG 05/05/2026 630.62 K $281.60 M   13.42% 0.25%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 04/30/2026 614.45 K $274.38 M   -6.12% 0.24%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 05/12/2026 597.50 K $266.81 M   5.52% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 561.10 K $250.55 M   15.74% 0.22%

Vertex Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 2208 institutional investors and hedge funds held shares of Vertex Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Capital World Investors: 25.37 M

BlackRock, Inc.: 23.97 M

Capital Research Global Investors: 21.13 M

STATE STREET CORP: 11.73 M

JPMORGAN CHASE & CO: 7.03 M

GEODE CAPITAL MANAGEMENT, LLC: 6.14 M

90.84% of Vertex Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 301.43 M shares in the last 24 months. This purchase volume represents approximately $138.92 B in transactions.